Caplin Point Laboratories Ltd share price logo

Caplin Point Laboratories Ltd

NSE: CAPLIPOINT

BSE: 524742

Small Cap

Pharma Sector

₹1998.80

-25.00

(-1.24%)

as on

bell
The current prices are delayed by 15 mins, login to check live prices.

Tech Chart

Caplin Point Stock Performance

as on May 15, 2026 at 9:31 pm IST

  • Day's Low

    Day's High

    ₹1,950.60
    ₹2,057.00
    downward going graph

    2.41%

    Downside

    2.91%

    Upside

    downward going graph

  • 52 Week's Low

    52 Week's High

    ₹1,500.30
    ₹2,395.00
    downward going graph

    24.94%

    Downside

    19.82%

    Upside

    downward going graph

Caplin Point share price movements today

Previous Close
₹2,023.80
Open
₹2,024.00
Volume
4.06L
Upper Circuit
₹2,428.50
Lower Circuit
₹1,619.10
Day's Low - High
₹1,950.60 - ₹2,057.00
52 Week Low - High
₹1,500.30 - ₹2,395.00

Caplin Point Historical Returns

1 Month Return
+ 16.61 %
3 Month Return
+ 17.92 %
1 Year Return
+ 1.16 %
3 Year Return
+ 186.07 %
5 Year Return
+ 221.37 %

Caplin Point Fundamentals

as on May 15, 2026 at 4:01 pm IST

Market Cap

₹15,383.25 Cr

Return on Equity (ROE)

21.97

PE Ratio (TTM)

23.99

Return on capital employed (ROCE)

28.5

Industry PE ratio

44.62

Beta (LTM)

0.87

P/B Ratio

8.95

Dividend Yield

0.3

PEG Ratio

1.74

Quarterly Earnings Growth YOY

19

EPS (TTM)

71.2

Sector

Pharmaceuticals

Book Value

346.57

Caplin Point Stock Valuation

as on May 15, 2026 at 4:01 pm IST

Caplin Point in the last 5 years

  • Overview

  • Trends

Lowest (6.76x)

March 24, 2020

Today (23.99x)

May 14, 2026

Industry (44.62x)

May 14, 2026

Highest (40.01x)

December 27, 2024

LowHigh

Today’s Price to Earnings Ratio: 23.99x

Caplin Point Technical Analysis

Track how Caplin Point technical analysis has moved over time to understand its trends.

1 min
5 min
15 min
30 min
1 day
1 week
1 month

Technicals Summary

Bearish

Neutral

Bullish

Bullish

Moving Averages

Bearish

Neutral

Bullish

Bullish

Oscillators

Bearish

Neutral

Bullish

Neutral

Overall

Bearish2
Bullish11
Neutral2

Oscillators

Name

Value

Action

MACD level (12,26)
3.03
Bullish
CCI (20)
108.99
Bearish
RSI (14)
63.95
Neutral
Momentum (10)
6.2
Bearish
ADI (14)
39.35
Bullish
Ultimate Oscillator (7,14,28)
49.59
Neutral

Moving Averages

Name

Value

Action

SMA (20)
1993.83
Bullish
EMA (20)
1995.6
Bullish
VWMA (20)
1996.68
Bullish
SMA (50)
1991.16
Bullish
EMA (50)
1993.76
Bullish
SMA (200)
1998.08
Bullish
EMA (200)
1996.43
Bullish
KAMA (200)
1991.72
Bullish
DEMA (200)
1999.17
Bullish

Caplin Point Laboratories Ltd vs Peer Comparison

Compare market cap, revenue, PE, and other key metrics of Caplin Point with its industry peers.

Company
Analyst View
Market Cap(in ₹ Cr)
5 Year CAGRDebt to Asset Ratio
Net Profit(in ₹ Cr)
Yearly Revenue(in ₹ Cr)
Caplin Point Laboratories Ltd image
Caplin Point Laboratories Ltd
BUY15,383.2544.27%0.515411,937
Cohance Lifesciences Ltd image
Cohance Lifesciences Ltd
BUY17,031.89-3.21%0.682641,197
Jubilant Pharmova Ltd image
Jubilant Pharmova Ltd
BUY16,000.094.13%0.718367,234
Sun Pharma Advanced Research Company Ltd image
Sun Pharma Advanced Research Company Ltd
BUY5,519.46-5.02%1.88-34371
Rainbow Childrens Medicare Ltd image
Rainbow Childrens Medicare Ltd
BUY13,367.2238.47%0.672441,515
See all

Market expectation of Caplin Point Stock

Common consensus of the market based on various publicly available news, publications,brokerage expectation and market data

BUY

100.00%

Buy

0.00%

Hold

0.00%

Sell

Caplin Point Stock’s Investor Sentiment and Interest

Investment in Caplin Point Laboratories Ltd Shares on INDmoney has grown by 146.28% over the past 30 days, indicating increased transactional activity.

Time period: to

Change:146.28% versus previous 30 day period

Search interest for Caplin Point Laboratories Ltd Stock has increased by 27% in the last 30 days, reflecting an upward trend in search activity.

Time period: to

Change:27% versus previous 30 day period

Caplin Point Laboratories Ltd Quarterly Profit & Loss

Figures in Rupees Crores

Jun 2023
Sep 2023
Dec 2023
Mar 2024
Jun 2024
Sep 2024
Dec 2024
Mar 2025
Jun 2025
Sep 2025
Dec 2025
Mar 2026
Sales
395.32
410.06
435.5
453.22
458.96
483.1
492.96
502.45
510.22
534.04
542.77
600.16
Other Income
12.12
20.54
17.2
17.35
18.58
20.77
31.36
25.82
23.17
30.39
33.68
28.36
Total Income
407.44
430.6
452.7
470.57
477.54
503.87
524.32
528.27
533.39
564.43
576.45
628.52
Expenses
268.79
272.66
293.22
307.99
307.15
318.44
330.68
334.39
332.46
344.87
353.1
395.92
Operating Profit
126.53
137.4
142.28
145.23
151.81
164.66
162.28
168.06
177.76
189.17
189.67
204.24
Operating Profit Margin %
32.01%
33.51%
32.67%
32.04%
33.08%
34.08%
32.92%
33.45%
34.84%
35.42%
34.94%
34.03%
Profit Before Interest, Tax and Depreciation
138.65
157.94
159.48
162.58
170.39
185.43
193.64
193.88
200.93
219.56
223.35
232.6
Interest
0.28
0.18
0.17
0.15
0.05
0.21
0.18
0.17
0.18
0.16
0.18
0.36
Depreciation
11.38
11.76
13.9
16.4
15.96
16.76
16.2
17.04
16.29
18.4
19.28
18.8
Profit Before Tax
126.99
146
145.41
146.03
154.38
168.46
177.26
176.67
184.46
201
203.89
213.44
Tax Paid
22.76
29.86
25.59
24.8
29.46
37.65
37.19
31.39
33.7
40.77
38.03
40.56
Profit After Tax
104.23
116.14
119.82
121.23
124.92
130.81
140.07
145.28
150.76
160.23
165.86
172.88
Total Net profit including share of profit / Loss from associate company
104.23
116.14
119.82
121.23
124.92
130.81
140.07
145.28
150.76
160.23
165.86
172.88
EPS
13.62
15.13
15.44
16.01
16.32
17.22
18.28
18.75
20.1
20.32
21.56
22.38
Actual EPS
13.62
15.13
15.44
16.01
16.32
17.22
18.28
18.75
20.1
20.32
21.56
22.38
Adjusted EPS
13.62
15.13
15.44
16.01
16.32
17.22
18.28
18.75
20.1
20.32
21.56
22.38
Diluted EPS
13.55
15.06
15.39
15.9
16.24
17.12
18.19
18.69
20.03
20.25
21.51
22.31

Caplin Point Laboratories Ltd Annual Profit & Loss

Figures in Rupees Crores

Mar 2018
Mar 2019
Mar 2020
Mar 2021
Mar 2022
Mar 2023
Mar 2024
Mar 2025
Mar 2026
Sales
539.84
648.69
863.2
1,061.29
1,269.41
1,466.73
1,694.1
1,937.47
2,187.19
Other Income
12.67
19.03
41.33
23.54
38.75
56.06
67.21
96.43
115.58
Total Income
552.51
667.72
904.53
1,084.83
1,308.16
1,522.79
1,761.31
2,033.9
2,302.77
Expenses
345.07
417.36
603.13
732.65
874.74
1,025.67
1,142.66
1,290.55
1,426.34
Operating Profit
194.77
231.33
260.07
328.64
394.67
441.06
551.44
646.92
760.85
Operating Profit Margin %
36.08%
35.66%
30.13%
30.97%
31.09%
30.07%
32.55%
33.39%
34.79%
Profit Before Interest, Tax and Depreciation
207.43
250.36
301.4
352.18
433.42
497.12
618.65
743.35
876.43
Interest
0.06
0.06
0.32
1.59
0.7
0.78
0.78
0.61
0.87
Depreciation
19
23.43
31.62
36.97
46.9
44.99
53.44
65.96
72.77
Profit Before Tax
188.37
226.87
269.46
313.62
385.82
451.35
564.43
676.78
802.79
Tax Paid
43.74
50.32
54.38
62.18
77.37
74.36
103.01
135.69
153.06
Profit After Tax
144.64
176.56
215.08
251.44
308.45
376.99
461.42
541.09
649.73
Total Net profit including share of profit / Loss from associate company
144.64
176.56
215.08
251.44
308.45
376.99
461.42
541.09
649.73
EPS
19.16
23.35
28.42
32.03
39.61
49.62
60.19
70.57
84.36
Actual EPS
19.16
23.35
28.42
32.03
39.61
49.62
60.19
70.57
84.36
Adjusted EPS
19.16
23.35
28.42
32.03
39.61
49.62
60.19
70.57
84.36
Diluted EPS
19.06
23.23
28.2
31.71
39.26
49.18
59.9
70.25
84.11

Caplin Point Laboratories Ltd Cash Flow

Figures in Rupees Crores

Mar 2016
Mar 2017
Mar 2018
Mar 2019
Mar 2020
Mar 2021
Mar 2022
Mar 2023
Mar 2024
Mar 2025
Net Cash from Operating Activities
42.4
67.61
66.49
83.42
44.68
268.61
336.73
271.37
318.39
432.37
Cash Flow from Investing Activities
-5.72
-36.1
-69.02
-99.74
-54.33
-29.68
-376.86
-216.4
-319.18
-333.3
Cash Flow from Financing Activities
-13.95
-6.75
-11.6
89.79
79.76
-23.98
-40.68
-28.17
-38.07
-38.32
Net Cash Flow
22.73
24.76
-14.14
73.48
70.11
214.95
-80.81
26.8
-38.86
60.75

Caplin Point Stock Shareholding Pattern

Numbers in percentages

Jun 2023
Sep 2023
Dec 2023
Mar 2024
Jun 2024
Sep 2024
Dec 2024
Mar 2025
Jun 2025
Sep 2025
Dec 2025
Mar 2026
Promoters
70.63%
70.63%
70.62%
70.62%
70.56%
70.56%
70.56%
70.56%
70.56%
70.57%
70.57%
70.57%
DII
0.26%
0.2%
0.43%
1.09%
1.49%
1.84%
2.11%
2.01%
2.22%
2.1%
2.05%
2.14%
FII
0%
3.09%
2.85%
3.34%
3.37%
3.7%
4.86%
5.73%
6.17%
6.51%
6.59%
6.15%
Public
26.42%
26.08%
26.1%
24.95%
24.57%
23.9%
22.47%
21.7%
21.05%
20.82%
20.79%
21.14%
Total Outstanding Shares
7,59,33,746
7,59,39,746
7,59,41,746
7,59,41,746
7,60,10,296
7,60,11,696
7,60,11,696
7,60,11,696
7,60,11,696
7,60,11,696
7,60,11,696
7,60,11,696
Total Shareholders
78,956
78,068
79,438
81,409
80,411
96,123
92,702
96,387
94,169
93,753
93,705
93,896

Mutual Funds that own Caplin Point Stock

Check out the Mutual Funds with significant holdings in Caplin Point.

Caplin Point Corporate Actions

View detailed summary of the earnings and dividend history of Caplin Point.

  • Caplin Point Laboratories Ltd Earnings Results

    Caplin Point Laboratories Ltd’s net profit jumped 19.32% since last year same period to ₹170.11Cr in the Q4 2025-2026. On a quarterly growth basis, Caplin Point Laboratories Ltd has generated 3.8% jump in its net profits since last 3-months.

    Read More about Earnings Results

  • Caplin Point Laboratories Ltd Dividends August,2025

    In the quarter ending June 2025, Caplin Point Laboratories Ltd has declared dividend of ₹3.00 per share on 07 Aug 2025 - translating a dividend yield of 0.42%.

    Read More about Dividends

Indices Featuring Caplin Point Stock

Check stock indices that include Caplin Point.

S&P BSE 250 SmallCap

₹6,685.19

-0.37 (▲24.94%)

Nifty 500

₹22,531.15

-0.36 (▲81.95%)

Nifty MidSmallcap 400

₹20,217.55

-0.43 (▲86.70%)

S&P BSE 400 MidSmallCap

₹12,038.81

-0.44 (▲53.47%)

BSE 500

₹35,236.50

-0.36 (▲127.94%)

BSE Healthcare

₹47,193.13

0.18 (▲84.87%)

Nifty Smallcap 250

₹16,722.90

-0.39 (▲66.10%)

Insights on Caplin Point Laboratories Ltd

Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.

  • imgPOSITIVE IMPACT

    Best in 3 Years

    img

    In the last 3 years, CAPLIPOINT has outperformed top 5 stocks with highest market-cap in Pharmaceuticals

  • imgPOSITIVE IMPACT

    Profit Spike

    img

    Netprofit is up for the last 18 quarters, 74.95 Cr → 170.11 Cr (in ₹), with an average increase of 4.7% per quarter

  • imgPOSITIVE IMPACT

    Revenue Rich

    img

    Revenue is up for the last 23 quarters, 269.88 Cr → 628.52 Cr (in ₹), with an average increase of 3.8% per quarter

  • imgPOSITIVE IMPACT

    MF Holding Up

    img

    Mutual Funds have increased holdings from 1.97% to 2.02% in Mar 2026 quarter

  • imgPOSITIVE IMPACT

    Retail Holding Up

    img

    Retail Investor have increased holdings from 20.79% to 21.14% in Mar 2026 quarter

  • imgPOSITIVE IMPACT

    Price Rise

    img

    In the last 7 days, CAPLIPOINT stock has moved up by 9.0%

  • imgNO EFFECT

    Against Peers

    img

    In the last 1 year, Torrent Pharmaceuticals Ltd has given 34.9% return, outperforming this stock by 33.7%

  • imgNO EFFECT

    Promoter Holding Unchanged

    img

    Promoters holdings remained unchanged at 70.57% of holdings in Mar 2026 quarter

  • imgNEGATIVE IMPACT

    FII Holding Down

    img

    Foreign Institutions have decreased holdings from 6.56% to 6.15% in Mar 2026 quarter

About Caplin Point Laboratories Ltd

Caplin Point Laboratories Limited was founded in the year 1990 and is a fully integrated transnational pharmaceutical company. With over 4000 product registrations covering 36 therapeutic segments, the company has set up its presence in 23 countries. It specializes in producing and marketing of wide range of generic formulations and branded products and exporting them to markets like the US, European Union, Africa, LATAM and others. The company has also established a trading branch in Nairobi Kenya and a warehouse in Miami USA in collaboration with Lockett Corp. It completed splitting its shares in 2016 from Rs. 10 to Rs. 2 each. As on date, the company has three subsidiaries in India, Hong Kong and Colombia. It invested in Argus Salud Pharma LLP and set up a Joint venture in China. It also ventured into the ecommerce space. In the year 2021, the company has already received four ANDA approvals and 8 product launches. It has planned to file more 18 ANDAs with an addressable market size of USD 1.95 billion and is investing a sum of Rs. 140 crores in setting up its second Injectable Plant with 2 Vial lines, a Lyophilizer line and a Pre filled syringe line.

Revenue: ₹600.16Cr as on March 2026 (Q4 FY26)
Net Profit: ₹172.88Cr as on March 2026 (Q4 FY26)
Listing date: 23 Jun, 2014
Chairperson Name: C C Paarthipan
OrganisationCaplin Point Laboratories Ltd
HeadquartersChennai
IndustryPharmaceuticals
CEOC C Paarthipan
E-voting on sharesClick here to vote

FAQs

What is Caplin Point share price today?

Caplin Point share price today stands at ₹1998.8 as on at the close of the market. Caplin Point share today touched a day high of ₹2057 and a low of ₹1950.6.

What is the 52 week high and 52 week low range for Caplin Point share?

Caplin Point touched a 52 week high of ₹2395 and a 52 week low of ₹1500.3. Caplin Point share price today i.e. is closed at ₹1998.8, which is -16.54% down from its 52 week high and 33.23% up from its 52 week low.

What is Caplin Point's market capitalisation today?

Caplin Point market capitalisation is ₹15,383.25 Cr as on .

How to buy Caplin Point shares?

To buy Caplin Point shares, you need to follow these steps:

  • Open a Demat account and Trading account on INDmoney
  • Fund your Trading account
  • Search for CAPLIPOINT or Caplin Point Laboratories Ltd on the INDmoney app to check live prices of the stock
  • Click on Buy or SIP to place an order to invest in Caplin Point shares. You can invest by selecting the number of shares or set up a fixed SIP to invest every month or week.

What is Caplin Point trading volume today?

Caplin Point trading volume is 4.06L as on . This means that 4.06L shares of Caplin Point were bought and sold on the stock market during today's trading session.